Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Amicus Therapeutics

02 6ENDO OPERATIONS LTD.

03 3ORIFARM GROUP AS

04 6SK Life Science

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cenobamatum

Brand Name : Ontozry

Dosage Form : Filmtabl

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

02

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cenobamatum

Brand Name : Ontozry

Dosage Form : Filmtabl

Dosage Strength : 100mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

03

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cenobamatum

Brand Name : Ontozry

Dosage Form : Filmtabl

Dosage Strength : 150mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

04

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cenobamatum

Brand Name : Ontozry

Dosage Form : Filmtabl

Dosage Strength : 150mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

05

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cenobamatum

Brand Name : Ontozry

Dosage Form : Filmtabl

Dosage Strength : 200mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

06

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cenobamatum

Brand Name : Ontozry

Dosage Form : Filmtabl

Dosage Strength : 200mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

07

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cenobamatum

Brand Name : Ontozry

Dosage Form : Filmtabl

Dosage Strength : 50mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

08

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cenobamatum

Brand Name : Ontozry

Dosage Form : Filmtabl

Dosage Strength : 50mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

09

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Cenobamatum

Brand Name : Ontozry Starterpackung

Dosage Form : Filmtabl

Dosage Strength : 12.5mg and 25mg

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

10

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Senobamat

Brand Name : Ontozory

Dosage Form : Tablet, film-coated

Dosage Strength : 200 mg

Packaging : Blisterpakning 28item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

11

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Senobamat

Brand Name : Ontozory

Dosage Form : Tablet, film-coated

Dosage Strength : 150 mg

Packaging : Blisterpakning 28item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

12

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

Senobamat

Brand Name : Ontozory

Dosage Form : Tablet, film-coated

Dosage Strength : 50 mg

Packaging : Blisterpakning 28item

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

13

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET;ORAL

Dosage Strength : 12.5MG

Packaging :

Approval Date : 2020-03-10

Application Number : 212839

Regulatory Info : RX

Registration Country : USA

blank

14

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET;ORAL

Dosage Strength : 25MG

Packaging :

Approval Date : 2020-03-10

Application Number : 212839

Regulatory Info : RX

Registration Country : USA

blank

15

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET;ORAL

Dosage Strength : 50MG

Packaging :

Approval Date : 2020-03-10

Application Number : 212839

Regulatory Info : RX

Registration Country : USA

blank

16

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET;ORAL

Dosage Strength : 100MG

Packaging :

Approval Date : 2020-03-10

Application Number : 212839

Regulatory Info : RX

Registration Country : USA

blank

17

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET;ORAL

Dosage Strength : 150MG

Packaging :

Approval Date : 2020-03-10

Application Number : 212839

Regulatory Info : RX

Registration Country : USA

blank

18

2024 ACI Convention
Not Confirmed
arrow
arrow
2024 ACI Convention
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET;ORAL

Dosage Strength : 200MG

Packaging :

Approval Date : 2020-03-10

Application Number : 212839

Regulatory Info : RX

Registration Country : USA

blank

19

ENDO OPERATIONS LTD.

Country
2024 ACI Convention
Not Confirmed
arrow

ENDO OPERATIONS LTD.

Country
arrow
2024 ACI Convention
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET

Dosage Strength : 12.5MG

Packaging :

Approval Date :

Application Number : 2538652

Regulatory Info : Prescription

Registration Country : Canada

blank

20

ENDO OPERATIONS LTD.

Country
2024 ACI Convention
Not Confirmed
arrow

ENDO OPERATIONS LTD.

Country
arrow
2024 ACI Convention
Not Confirmed

CENOBAMATE

Brand Name : XCOPRI

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging :

Approval Date :

Application Number : 2538660

Regulatory Info : Prescription

Registration Country : Canada

blank